All releases

27 recent releases from TMX Newsfile, newest first, refreshed every 5 minutes. This list follows a fixed rule; nothing in it is chosen, ranked or paid for. Times are Eastern.

Friday, November 13, 2026

5:22 PM ETNoveris Health Sciences Inc.CSE: NVRSFSE: 0NF1OTC Pink: MYCOFTMX Newsfile
Noveris Health Sciences Announces Commencement of Strategic Review Process
Noveris Health Sciences Inc. announces that its board of directors (the "Board") has commenced a strategic review process to evaluate the strategic and financial alternatives available to the Company (the "Strategic…
3:03 PM ETDelivra Health Brands Inc.TSXV: DHBOTCQB: DHBUFTMX Newsfile
Delivra Health Issues News Release Amendment Regarding Proposed Shares for Debt Transaction
Delivra Health, hereby issues a correction to its news release dated November 11, 2026 (the "Prior Release") regarding a shares for payables settlement agreement to satisfy an aggregate of approximately $90,000 of the…
8:30 AM ETNYSE American: OSTXTMX Newsfile
OS Therapies Announces Shelving of U.S. FDA Commissioner's National Priority Voucher Has No Impact on the Company
OS Therapies, the world leader in gene-edited, Listeria-based cancer…
7:00 AM ETVesalius Longevity Labs Inc.CSE: VLABTMX Newsfile
Vesalius Longevity Labs Appoints Harvey Spevak as Chairman to Accelerate Global Growth and Brand Development
Vesalius, a leading global peptide and longevity company, today announced the appointment of Harvey Spevak, as Chairman of its Board of Directors, effective November 13, 2026. The appointment follows a US$6.5 million…

Thursday, November 12, 2026

8:05 PM ETAppili Therapeutics Inc. (NEX: APLI.H)OTC Pink: APLIFTMX Newsfile
Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2027
Appili Therapeutics Inc. (NEX: APLI.H) (OTC Pink: APLIF) (the "Company" or "Appili"), a biopharmaceutical company building a National Security Healthcare platform focused on dual-use medical technologies, today…
8:04 PM ETTherma Bright Inc.TSXV: THRMOTCQB: TBRIFFSE: JNX0TMX Newsfile
Therma Bright Increases Non-Brokered Private Placement up to $500,000
Therma Bright, a developer and investment partner specializing in advanced medical device technologies, announces that further to its news release of October 23, 2026, it has received interest above the previously…
8:00 AM ETKALA BIO, Inc.NASDAQ: KALATMX Newsfile
KALA BIO Announces Reverse Stock Split
KALA BIO, today announced that it intends to effect a reverse stock split of its common stock, par value $0.001 per share (the "common stock"), at a ratio of 1 post-split share for every 30 pre-split shares. The reverse…
7:07 AM ETCharlotte's Web Holdings, Inc.TSX: CWEBOTCQX: CWBHFTMX Newsfile
Charlotte's Web Reports Third Quarter 2026 Financial Results
Charlotte's Web, a botanical wellness innovation company and a market leader in cannabidiol (CBD) hemp extract wellness products, today announced results for the quarter ended September 30, 2026. All amounts are…
7:00 AM ETVesalius Longevity Labs Inc.CSE: VLABTMX Newsfile
Vesalius Longevity Labs Commences Trading Today on the Canadian Securities Exchange Under the Symbol "VLAB"
Vesalius is pleased to announce that it will commence trading on the Canadian Securities Exchange ("CSE") under the symbol "VLAB" today, November 12, 2026. "Today marks an important milestone for Vesalius Labs, and I…
7:00 AM ETKiora Pharmaceuticals, Inc.NASDAQ: KPRXTMX Newsfile
Kiora Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Kiora today reported financial results for the third quarter ended September 30, 2026, and provided a business update highlighted by the in-licensing of KIO-401, a late-stage, oral neuroprotective calpain inhibitor. The…
7:00 AM ETPhio Pharmaceuticals Corp.NASDAQ: PHIOTMX Newsfile
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
Phio Pharmaceuticals Corp. is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio Pharmaceuticals announced today…
6:00 AM ETNASDAQ: BHSTTMX Newsfile
BioHarvest Reports Third Quarter 2026 Financial Results and Provides Business Update
BioHarvest Sciences Inc (TASE: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today reported financial results for the three and nine months ended…

Wednesday, November 11, 2026

3:05 PM ETDelivra Health Brands Inc.TSXV: DHBOTCQB: DHBUFTMX Newsfile
Delivra Health Announces Proposed Shares for Debt Transaction
Delivra Health, a consumer packaged goods company uniquely positioned in the health and wellness sector, is pleased to announce it has entered into a shares for payables settlement agreement (the "Agreement"), to…
9:00 AM ETTMX Newsfile
Independent Expert Panel Unanimously Concludes FloraWorks' TruCBN(TM) Is GRAS at up to 50 mg Daily
FloraWorks, a cannabinoid biotechnology company, today announced that an independent panel of scientific experts unanimously concluded its proprietary, high-purity cannabinol (CBN) ingredient, TruCBN™, is Generally…

Monday, November 9, 2026

5:00 PM ETQuinsam Capital CorporationCSE: QCATMX Newsfile
Quinsam Announces Q3/2026 Results
Quinsam is announcing its Q3/2026 results, with net income of $0.1 million ($0.001 per share basic, $0.001 fully diluted) versus net income of $0.1 million ($0.001 per share basic, $0.001 fully diluted) in Q3/2025.…
7:31 AM ETRhelion Life Sciences Corp.CSE: RHELFSE: 4YX0OTCQB: TRUFFTMX Newsfile
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Ships PEX010 to King's College London
Rhelion an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly owned subsidiary Filament Health Corp. ("Filament"), the Company develops, manufactures and…

Friday, November 6, 2026

4:15 PM ETPsyched Wellness Ltd.CSE: PSYCTMX Newsfile
Psyched Wellness Announces Secured Term Loan
Psyched Wellness Ltd. (OTCID: PSYCF) (FSE: 5U9) (the "Company" or "Psyched Wellness"), a life sciences company focused on the production and distribution of Amanita Muscaria-derived health and wellness products…

Thursday, November 5, 2026

4:30 PM ETDoseology Sciences Inc.CSE: MOODOTCQB: DOSEFFSE: VU70TMX Newsfile
Doseology Announces Revocation of MCTO and Adoption of Semi-Annual Financial Reporting
Doseology announces revocation of the management cease trade order ("MCTO") previously issued on October 29, 2026; and its intention to voluntarily adopt the Semi-Annual Reporting ("SAR") Pilot Program pursuant to…
2:52 PM ETDigicann Ventures Inc.CSE: DCNN.XTMX Newsfile
Digicann Ventures Signs Definitive Share Exchange Agreement with Winning Asia Technology Macau Limited for Proposed Reverse Takeover Transaction
Digicann is pleased to announce that, further to its news release dated June 5, 2026, it has entered into a binding share exchange agreement (the "Definitive Agreement") dated October 31, 2026 and signed on November 4…

Tuesday, November 3, 2026

8:02 AM ETCSE: RHELFSE: 4YXOTCQB: TRUFFTMX Newsfile
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Ships PEX010 to the University of Southern California for the Expanded Mindfulness Assisted Psychedelic Therapy Trial
Rhelion an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly owned subsidiary Filament Health Corp. ("Filament"),…
6:30 AM ETCSE: VEXTTMX Newsfile
Vext Reports Q3 2026 Financial Results; Record Quarterly Revenue of $14.9 Million; Operating Cash Flow of $2.4 Million
Record quarterly revenue of $14.9 million, up 23% from Q2 2026 and 18% year-over-year. Ohio revenue up 37% year-over-year to $10.9 million, led by Fairfield and Company-grown flower. Operating cash flow of $2.4 million…

Monday, November 2, 2026

8:30 PM ETNeural Therapeutics Inc.CSE: NURLFSE: HANFTMX Newsfile
Neural Therapeutics Provides Corporate Update
Neural announces a change to its Board of Directors and provides updates regarding its previously announced transaction with CWE European Holdings Inc. ("CWE").Board of DirectorsThe Company announces that John Durfy has…
7:37 AM ETCSE: RHELFSE: 4YX0OTCQB: TRUFFTMX Newsfile
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Completes New Extraction of IBEX011, Its Naturally Derived Ibogaine Drug Candidate, and Commences Stability Testing
Rhelion, an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly owned subsidiary Filament Health Corp. ("Filament"), the Company develops, manufactures and…

Thursday, October 29, 2026

5:30 PM ETDoseology Sciences Inc.CSE: MOODOTCQB: DOSEFFSE: VU70TMX Newsfile
Doseology Announces Management Cease Trade Order for Late Filing of Annual Audited Financial Statements
Doseology, a consumer product innovation company focused on oral pouch and functional stimulant product technologies, announces that it was unable to file its annual audited financial statements, management's discussion…

Wednesday, October 28, 2026

8:00 AM ETCSE: RHELFSE: 4YX0OTCQB: TRUFFTMX Newsfile
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Signs Agreement to Supply PEX010 to Linkoping University for PsiloSAD Trial in Social Anxiety Disorder
Rhelion an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly owned subsidiary Filament Health Corp. ("Filament"), the Company…

Friday, October 16, 2026

8:55 AM ETCSE: RHELFSE: 4YX0OTCQB: TRUFFTMX Newsfile
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health to Supply Belgium's First Psilocybin Compassionate Use Program, to Help Open the Door to Patient Access for Treatment-Resistant Depression
Rhelion an Ontario-based organization advancing…

Wednesday, October 14, 2026

6:00 PM ETDoseology Sciences Inc.CSE: MOODOTCQB: DOSEFFSE: VU70TMX Newsfile
Doseology Announces Resignation of Director
Doseology a consumer product innovation company focused on oral pouch and functional stimulant product technologies, announces that Larry Latowsky has resigned as a director of the Company, effective immediately. About…